Journey Medical Corp Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Journey Medical Corp quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Journey Medical Corp Debt-to-equity for the quarter ending September 30, 2024 was 391 %, a 44.5% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	391	-313	-44.5%	Sep 30, 2024
Q2 2024	343	-305	-47.1%	Jun 30, 2024
Q1 2024	451	+56.1	+14.2%	Mar 31, 2024
Q4 2023	582	+307	+112%	Dec 31, 2023
Q3 2023	704	+500	+245%	Sep 30, 2023
Q2 2023	648	+353	+120%	Jun 30, 2023
Q1 2023	395			Mar 31, 2023
Q4 2022	275			Dec 31, 2022
Q3 2022	204			Sep 30, 2022
Q2 2022	295			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.